ebook Munafa Stock Market Course + Intraday & FNO calls  

       

MARKSANS announcements Marksans Pharma Limited announcements and dividends declared NSE

Marksans Pharma Limited Complete list of announcements declared & dividend announcements by Marksans Pharma Limited MARKSANS

Marksans Pharma Limited MARKSANS listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Marksans Pharma Limited MARKSANS

Company Announcement
Marksans Pharma Limited has informed the Exchange about Transcript
Announcement as on 21 November 2025

Company Announcement
Marksans Pharma Limited has informed the Exchange regarding a press release dated November 20, 2025, titled "Marksans Pharma Limited's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its product Cetirizine Dihydrochloride 1 m
Announcement as on 20 November 2025

Company Announcement
Marksans Pharma Limited has informed the Exchange regarding a press release dated November 19, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary Marksans Pharma Inc. receives USFDA approval for Loperamide Hydrochloride Tablets USP, 2 mg (OTC)
Announcement as on 19 November 2025

Company Announcement
Marksans Pharma Limited has informed the Exchange about Copy of Newspaper Publication regarding unaudited financial results for the quarter and half year ended September 30, 2025.
Announcement as on 17 November 2025

Company Announcement
Marksans Pharma Limited has informed the Exchange regarding a press release dated November 17, 2025, titled "Marksans Pharma Limited's wholly owned subsidiary Relonchem Limited receives Marketing Authorisation for its Products from UK MHRA.".
Announcement as on 17 November 2025

Announcements by Marksans Pharma Limited first page | Next page | Prev page |

MARKSANS Marksans Pharma Limited current price & indicator signals

Moving Averages for Marksans Pharma Limited

  • 5Day Average: 202.24
  • 12Day Average: 196.4
  • 20Day Average: 191.45
  • 50Day Average: 178.39
  • 100Day Average: 177.59
  • 150Day Average: 180.07
  • 200Day Average: 182.11

MARKSANS Indicators & signals

Indicator MACD (12,26,9)

197.35, 189.96, 6.33
Indicator MACD is in positive zone

Indicator ADX (14)

44.71, 27.95, 10.68
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 55
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of MARKSANS Marksans Pharma Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
15 Fri May 2026 207.45 200.05 to 213.45 2.74% 1.68 times
14 Thu May 2026 201.92 197.41 to 206.00 0.89% 0.62 times
13 Wed May 2026 200.13 197.02 to 203.00 0.87% 0.46 times
12 Tue May 2026 198.40 197.40 to 207.26 -2.4% 0.85 times
11 Mon May 2026 203.28 193.75 to 208.65 2.79% 1.39 times
08 Fri May 2026 197.76 197.22 to 205.90 -2.59% 0.68 times
07 Thu May 2026 203.02 197.70 to 204.00 3.48% 1.16 times
06 Wed May 2026 196.20 188.30 to 207.00 4.96% 3.83 times
05 Tue May 2026 186.92 185.00 to 190.60 -1.25% 0.28 times
04 Mon May 2026 189.29 186.35 to 193.33 2.52% 0.46 times
30 Thu Apr 2026 184.63 181.00 to 187.88 -1.67% 0.26 times
29 Wed Apr 2026 187.76 185.00 to 191.10 1.99% 0.36 times

Videos related to: MARKSANS announcements Marksans Pharma Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

MARKSANS announcements Marksans Pharma Limited announcements and dividends declared NSE

 

Back to top